Inflammation has been implicated in the pathogenesis of endothelial dysfunction,
atherosclerosis, and microvascular coronary dysfunction. In this context, it is thought that …

Background Systemic immune-inflammation index (SII, platelet× neutrophil/lymphocyte
ratio), a new marker of inflammation, is associated with adverse cardiovascular events, but …

Background Although the pathophysiology of coronary slow flow (CSF) has not been fully
elucidated, emerging data increasingly support potential role for subclinical diffuse …

Aim Recently, lymphocyte-to-monocyte ratio (LMR) has emerged as a new indirect marker of
inflammation which is associated with adverse outcomes in oncology and cardiovascular …

Previous studies showed that both inflammation and platelets have a role in development of
slow coronary flow (SCF). Platelet to lymphocyte ratio (PLR) as an emerging inflammatory …

Background: Many inflammation-based markers (IBMs) have been shown to be closely
related to coronary slow flow (CSF), but the effect of the uric acid/albumin ratio (UAR) on …

The aim of the study is to investigate the association between the severity of rheumatic mitral
valvular disease (RMVD) and the neutrophil–lymphocyte ratio (NLR). A total of 227 patients …

Purpose The slow coronary flow (SCF) was identified as delayed opacification of epicardial
coronary arteries in the absence of stenotic lesion. Metabolic syndrome (MetS), oxidative …

Objectives: In this study, we aimed to investigate the relationship between neutrophil to
lymphocyte ratio (NLR) and infarct-related artery (IRA) patency in patients with ST-segment …

Introduction: In this study, we aimed to determine if neutrophil to lymphocyte ratio could
predict long term morbidity and mortality in patients who hospitalized for non-ST segment …